Search research articles
Contact Us
Filters
Showing results (371-380 of 621) with videos related to
Page
of 63
Sort By:
Current Oncology (Toronto, Ont.)
|
June 25, 2025
Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency Ablation
Jennifer W S Pang, Daniel Tong, Nicos Fotiadis, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 16, 2015
Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantation
Stuart W Grant, Graeme L Hickey, Peter Ludman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
December 21, 2018
Exercise intensity affects acute neurotrophic and neurophysiological responses poststroke
Pierce Boyne, Colleen Meyrose, Jennifer Westover, et al.
Journal for Immunotherapy of Cancer
|
December 17, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1
Gary Middleton, Charlotte Gaskell, Joshua Savage, et al.
International Journal of Cancer
|
December 31, 2013
Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer
Maressa A Bruhn, Amanda R Townsend, Chee Khoon Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 11, 2008
Bleeding in cardiac surgery: the use of aprotinin does not affect survival
Domenico Pagano, Neil J Howell, Nick Freemantle, et al.
The Lancet. Oncology
|
February 18, 2017
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
Robert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, et al.
British Journal of Haematology
|
July 5, 2020
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
N George Mikhaeel, David Cunningham, Nicholas Counsell, et al.
Journal of the American Heart Association
|
May 22, 2016
Death and Emergency Readmission of Infants Discharged After Interventions for Congenital Heart Disease: A National Study of 7643 Infants to Inform Service Improvement
Sonya Crowe, Deborah A Ridout, Rachel Knowles, et al.
Pathology, Research and Practice
|
January 22, 2025
Intra-patient comparison of microarchitecture of tumour negative lymph nodes from oesophageal cancer patients - Results from the MRC Oe02 trial
Maximilian Kloft, Elzbieta Budginaite, Sander M J van Kuijk, et al.
Page
of 63
Search research articles
Search
Showing results (371-380 of 621) with videos related to
Sort By:
Page
of 63
Current Oncology (Toronto, Ont.)
|
June 25, 2025
Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency Ablation
Jennifer W S Pang, Daniel Tong, Nicos Fotiadis, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 16, 2015
Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantation
Stuart W Grant, Graeme L Hickey, Peter Ludman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
December 21, 2018
Exercise intensity affects acute neurotrophic and neurophysiological responses poststroke
Pierce Boyne, Colleen Meyrose, Jennifer Westover, et al.
Journal for Immunotherapy of Cancer
|
December 17, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1
Gary Middleton, Charlotte Gaskell, Joshua Savage, et al.
International Journal of Cancer
|
December 31, 2013
Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer
Maressa A Bruhn, Amanda R Townsend, Chee Khoon Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 11, 2008
Bleeding in cardiac surgery: the use of aprotinin does not affect survival
Domenico Pagano, Neil J Howell, Nick Freemantle, et al.
The Lancet. Oncology
|
February 18, 2017
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
Robert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, et al.
British Journal of Haematology
|
July 5, 2020
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
N George Mikhaeel, David Cunningham, Nicholas Counsell, et al.
Journal of the American Heart Association
|
May 22, 2016
Death and Emergency Readmission of Infants Discharged After Interventions for Congenital Heart Disease: A National Study of 7643 Infants to Inform Service Improvement
Sonya Crowe, Deborah A Ridout, Rachel Knowles, et al.
Pathology, Research and Practice
|
January 22, 2025
Intra-patient comparison of microarchitecture of tumour negative lymph nodes from oesophageal cancer patients - Results from the MRC Oe02 trial
Maximilian Kloft, Elzbieta Budginaite, Sander M J van Kuijk, et al.
Page
of 63